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Abstract
Background: Electromyography (EMG) alterations during gait, supposedly caused by diabetic sensorimotor
polyneuropathy, are subtle and still inconsistent, due to difficulties in defining homogeneous experimental groups
with a clear definition of disease stages. Since evaluating these patients involve many uncertainties, the use of a
fuzzy model could enable a better discrimination among different stages of diabetic polyneuropathy and lead to a
clarification of when changes in muscle activation start occurring. The aim of this study was to investigate EMG
patterns during gait in diabetic individuals with different stages of DSP severity, classified by a fuzzy system.
Methods: 147 subjects were divided into a control group (n = 30) and four diabetic groups: absent (n = 43),
mild (n = 30), moderate (n = 16), and severe (n = 28) neuropathy, classified by a fuzzy model. The EMG activity of
the vastus lateralis, tibialis anterior, and gastrocnemius medialis were measured during gait. Temporal and relative
magnitude variables were compared among groups using ANOVA tests.
Results: Muscle activity changes are present even before an established neural involvement, with delay in vastus
lateralis peak and lower tibialis anterior relative magnitude. These alterations suggest an impaired ankle shock
absorption mechanism, with compensation at the knee. This condition seems to be more pronounced in higher
degrees of neuropathy, as there is an increased vastus lateralis activity in the mild and severe neuropathy groups.
Tibialis anterior onset at terminal stance was anticipated in all diabetic groups; at higher degrees of neuropathy,
the gastrocnemius medialis exhibited activity reduction and peak delay.
Conclusion: EMG alterations in the vastus lateralis and tibialis anterior occur even in the absence of diabetic
neuropathy and in mild neuropathic subjects, seemingly causing changes in the shock absorption mechanisms at
the heel strike. These changes increase with the onset of neural impairments, and the gastrocnemius medialis
starts presenting altered activity in the later stages of the disease (moderate and severe neuropathy). The degree
of severity of diabetic neuropathy must be taken into account when analyzing diabetic patients’ biomechanical
patterns of locomotion; we recommend the use of a fuzzy model for classification of disease stages.
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Background
Diabetic sensorimotor polyneuropathy (DSP) is believed
to cause changes in muscle activity during gait. However,
the literature has been inconsistent, with results that are
not always reproducible, and which sometimes produce
contradictions among studies, even when similar research
methods are used. One potential explanation for these
results is an imprecise and variable definition of diagnosis
and classification criteria for DSP, leading to an over- or
underestimation of the disease status [1]. Depending on
the type of the assessment, authors may have allocated
neuropathic individuals to groups considered free from
this condition, and vice-versa.
Studies on lower limb EMG during gait in this popula-
tion have resulted in insights regarding the generation
and control of this motor task. Patients with DSP have
shown delayed peak activity of the vastus lateralis and
tibialis anterior at heel strike [2-4]; prolonged activity of
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the tibialis anterior associated with early onset of the
soleus and gastrocnemius medialis during foot-flat phase
[5], and delayed peak activity of the gastrocnemius later-
alis and medialis at the propulsion phase [3,6]. Altered
activity of the vastus lateralis and tibialis anterior have
also been evident during stair negotiation [7], suggesting
that these muscles play different roles when DSP is
present. Although these findings are said to be con-
nected to the presence of DSP, diabetic individuals
without DSP also present differences in EMG patterns,
such as prolonged activity of the vastus medialis at
stance phase [8], and an anticipation of rectus femoris
and gastrocnemius lateralis peak [9], which opposes the
delayed activity found in patients with DSP [2,3,6].
Neurological signs and symptoms, and electrophysio-
logical measurements are the most common methods
for diagnosing DSP [10]. However, despite their higher
reliability, nerve conduction studies are less accessible
due to high cost, necessity of specialized professionals
and equipment, and their occasionally invasive nature.
Clinical assessment instruments provide simple and
inexpensive options for the evaluation of DSP [11], but
their results have shown to be variable when reproduci-
bility and accuracy were analyzed [1,12,13], even when
used as a composite score [13-15]. Furthermore, despite
the possibility of combining different types of assess-
ments, there are no objective criteria to interpret the
association of those results, leaving the diagnosis to
either a subjective decision by the health professional or
a grading system that generates an outcome score by a
simple sum.
In such a scenario, with unclear boundaries between
sickness and health, the Theory of Fuzzy Sets can be a
useful method for classifying these patients, as it takes
into account the uncertainties of the clinical assessment
of this illness, and it is capable of objectively measuring
a subjective judgment. This tool could be useful for diag-
nosing and classifying DSP, as DSP evolves continuously
from the onset of diabetes mellitus.
Duckstein et al. [16] have proposed a classification of
this neurological disorder using fuzzy logic, but the
input parameters they used were extracted from nerve
conduction studies. Although it was an interesting
approach, it relied on an invasive assessment method
with accessibility limitations, and the sensitivity test was
performed by comparing the fuzzy system’s output with
the authors’ own classification criteria, leading to a
possible bias. In another approach, Picon et al. [17]
developed a fuzzy system, using clinical parameters as
input variables, and they compared the output results
with the opinions of health professionals who were DSP
experts. However, even with good sensitivity and specifi-
city, this system had a few drawbacks, such as overvalu-
ation of disease symptoms on top of neurological signs,
and the use of confounding factors, such as the last
HbA1c level, a parameter that represents only a short
period of the history of diabetes control.
The purpose of the present study was to investigate the
lower limb EMG patterns of patients with different de-
grees of DSP severity, with each stage separated using a
fuzzy model that uses simple clinical assessment methods
as input variables. Our theses were that the use of fuzzy
logic would enable a better distinction among the different
stages of the disease and that muscle activation would be
altered even before the onset of DSP, with increased
effects in the more severe degrees of neuropathy.
Methods
Subjects
For this prospective study, 147 adult volunteers of both
genders were divided into a control group of non-
diabetic subjects (C; n = 30) and four diabetic groups,
classified by means of a fuzzy system: non-neuropathic
diabetic group (D; n = 43) and diabetic individuals with
mild (MiN; n = 30), moderate (MoN, n = 16), and severe
(SN; n = 28) neuropathy.
The inclusion criteria were: age under 65 years;
absence of partial or total lower limb amputation or
other neurological or orthopedic impairments due to
stroke, cerebral palsy, poliomyelitis, rheumatoid arthritis,
prosthesis, or moderate or severe osteoarthritis; major
vascular complications (venous or arterial ulcers); severe
retinopathy; severe nephropathy causing edema or requir-
ing hemodialysis; absence of plantar ulcer at the time of
evaluation; and ability to walk independently without pain
or the use of an assistive device.
The research protocol was approved by the ethics
committee of Faculdade de Medicina da Universidade de
Sao Paulo (Protocol# 292/10), under the resolution 196/
96 of the National Health Counsel, which is in accordance
to the Declaration of Helsinki. All participants signed an
informed consent form before entering the study.
All subjects underwent a clinical assessment, perfor-
med by a trained physical therapist, in which the following
clinical parameters were evaluated: (a) vibratory percep-
tion with a 128 Hz tuning fork; (b) tactile sensitivity with
a 10 g Semmes–Weinstein monofilament; and (c) typical
neuropathy symptoms assessment, by means of a ques-
tionnaire based on the Michigan Neuropathy Screening
Instrument [18]. These three groups of variables were
used as linguistic inputs in a fuzzy model, based on Picon
et al. [2012], to classify the patients into different disease
severity stages. Only clinical assessment methods regularly
used by health professionals, that are accessible and easily
performable by any health professional were included in
our evaluation.
Sociodemographic and clinical data of the experimen-
tal groups are described in Table 1. The groups differed
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in gender distribution, and all diabetic groups showed
greater body mass index when compared to Group C.
As expected, the duration of diabetes in Group D was
shorter than in all the neuropathic groups; glycemia was
higher in Group SN compared with D and MiN; and the
neuropathy output score from the fuzzy model increased
significantly as the degree of DSP increased.
Subject classification: Fuzzy system
The fuzzy system classifies each input variables into
fuzzy sets (fuzzification process) and performs a com-
binatory analysis of those variables by the Mamdani
inference process [19], linking those combinations with
fuzzy output sets. Then, by center of area defuzzification
method, the resulting output sets are transformed into a
numerical value. The model in this study used vibratory
perception, tactile sensitivity, and symptoms assessment
as the system´s inputs (Figure 1), and the combination
among them determined the fuzzy output sets of the
neuropathy degree (Figure 2) to which the subjects would
be allocated, and the respective membership degree of
each set. Finally, the defuzzification process produced the
final “neuropathy degree score”. This value was sorted into
the disease classes with the following division, with x
being the score value: (i) x ≤ 2.5: absent neuropathy; (ii)
2.5 < x < 5.0: mild neuropathy; (iii) 5.0 ≤ x < 8.0: moderate
neuropathy; (iv) x ≥ 8.0: severe neuropathy.
The fuzzy model presented a very strong correlation
[20] with the experts’ opinion (Pearson’s coefficient
r = 0.943) and a high accuracy level when classifying
real patients that underwent the model’s analysis (ROC
curve area = 0.91). More details of the system for classify-
ing DSP may be found on the study of Picon et al. [17] in
which the model used in this research was based on.
Experimental procedures
The EMGs of the vastus lateralis (VL), tibialis anterior
(TA), and gastrocnemius medialis (GM) muscles of one
lower limb were measured during the stance phase of
barefoot gait, as performed and described in our previ-
ous studies [6,7]. These muscles were chosen due to
their role in gait progression (VL and GM), as well as
knee and ankle impact attenuation (VL and TA) [21].
Furthermore, EMG activity of these muscles is often
reported in gait studies [2,3,5,22], because there is less
subcutaneous body fat-associated impedance, allowing a
better comparison with the literature.
For data acquisition, an EMG system (model 800C;
EMG System do Brasil, São José dos Campos, Brazil)
with a signal amplification factor of 1000 was used. Dis-
posable Ag/AgCl circular electrodes (10 mm diameter)
were placed over each muscle with a center-to-center
interelectrode distance of 20 mm, following the recom-
mendations of Sacco et al. [23] for placement location,
which is based on SENIAM. After shaving and cleaning
the skin with alcohol, the electrodes were attached using
Transpore 3MW adhesive tape and an elastic band, to
avoid movement artifacts.
The subjects were instructed to walk at a self-selected
cadence across a 10 m walkway with a force plate embed-
ded in its center (model OR61000; AMTI, Watertown,
MA). The electrode cables were held by a technician, who
ensured that they were not overstretched or slapped
against anything, while checking for any major gait devi-
ation in ground reaction force during the data acquisition.
EMG data were synchronized to the ground reaction force
at a sampling rate of 2 kHz (A/D Board DT3002, 12 bits,
AMTI), and five trials for each participant were collected.
Data acquisition only started after a period of adaptation
to the laboratory environment and equipment, when the
subject demonstrated a regular gait pattern, without gross
variation, confirmed by visual inspection of the vertical
ground reaction force curve.
Data processing
EMG activity was first processed to enable the extraction
of linear envelopes. After removing the offset from the
raw EMG, when necessary, the signal underwent a zero-
lag fourth-order Butterworth filter with a band-pass
width of 20–500 Hz, followed by full-wave rectification
and low-pass filtering at 5 Hz. The linear envelope had
its magnitude normalized by the EMG mean value and
Table 1 Sociodemographic variables and data related to diabetes mellitus for the experimental groups
Control
(n = 30)
Diabetes no-neuropathy
(n = 43)
Mild neuropathy
(n = 30)
Moderate neuropathy
(n = 16)
Severe neuropathy
(n = 28)
p
Age (years) 54.1 ± 7.5 56.7 ± 6.8 56.1 ± 6.3 58.4 ± 4.8 55.5 ± 6.8 0.3461
Sex (% female) 53.3 41.9 60.0 25.0 25.0 0.0273
BMI (kg/m2) 25.7 ± 3.9* 28.4 ± 3.9 28.5 ± 4.3 29.5 ± 4.6 28.6 ± 3.7 0.0091
DM duration (years) - 8.1 ± 7.2* 12.1 ± 8.2 13.7 ± 5.9 14.4 ± 6.9 0.0032
Glycemia (mg/dL) - 143.1 ± 56.6 156.5 ± 62.6 185.3 ± 98.1 197.9 ± 76.3a 0,0042
Fuzzy neuropathy
degree (score)
- 0.9 ± 0.5* 2.9 ± 0.9* 5.9 ± 1.1* 8.9 ± 1.1* <0.0012
1ANOVA; 2Kruskal-Wallis test; 3chi-square test *statistically different group; astatistically different from diabetes and mild neuropathy; BMI – body mass index.
Watari et al. Journal of NeuroEngineering and Rehabilitation 2014, 11:11 Page 3 of 9
http://www.jneuroengrehab.com/content/11/1/11
Figure 1 Fuzzy sets of the system´s input variables. Vibratory perception and tactile sensitivity were classified into: “Mildly altered”, “Altered” or
“Very altered”. Symptoms were classified into: “Very mild”, “Mild”, “Moderate” or “Severe”. The graphical representation of each fuzzy set displays the
membership degree that corresponds to a given value of the input variable.
Figure 2 Fuzzy output sets of the neuropathy degree. Neuropathy degree was classified into: “Absent”, “Mild”, “Moderate”, “High” or “Severe”.
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was time normalized by the stance phase period, deter-
mined by the ground reaction force data.
The analyzed variables are shown in Figure 3: (i)
relative magnitude of all three muscles, represented by
the percentage of peak activity in relation to the mini-
mum activity (VL1/VL2, TA1/TA2, and GM1/GM2); (ii)
relative magnitude of TA at pushoff phase, represented
by the percentage of the value of last peak activity in
relation to minimum activity (TA3/TA2); (iii) time to
peak occurrence (from 0 to 100% of stance phase) of all
muscles (VL1, TA1, and GM1); and (iv) onset time [24]
of GM (GMon) and of TA (TAon) in the terminal stance
(last 25% of stance phase).
All data processing was performed with a custom-
written MATLAB (version 7.8) function, and to ensure
the validity of the computer-derived variables, each signal
underwent visual inspection to identify possible move-
ment artifacts or any other interference that could com-
promise the procedure.
Statistical analysis
The EMG variables and sociodemographic and clinical data
were tested for normal distribution with the Kolmogorov–
Smirnov test. Inter-group comparisons of variables with
non-normal distribution patterns were performed with the
non-parametric Kruskal–Wallis test and the comparisons
of normal distributed variables were performed by ANOVA
tests followed by Neumann–Keuls post hoc (alpha error
level of 5%). Gender distribution among groups was com-
pared using a chi-square test. Statistics were performed
with the Statistica software (v.9; StatSoft, Inc.).
Results
All three muscles displayed changes in EMG activity at
some point of the disease, but they did not occur with a
defined pattern (Table 2, Figure 4). All the diabetic groups,
except MoN, had a tendency to delay the peak activity of
VL, although only Groups D and SN showed a significant
difference compared to the other groups (Figure 5).
Groups SN and MiN presented a higher relative mag-
nitude of VL, while MoN had the lowest activity among
diabetic groups.
The TA relative magnitude was lower for all diabetic
groups compared to Group C, although this comparison
was not statistically significant for SN. The activation
onset of TA at late stance occurred earlier in the diabetic
groups, both with and without neuropathy, and it was
more evident in Groups D and SN. Regarding the
relative magnitude at the end of stance phase, Group C
had the lowest activity overall, but only D presented a
significantly higher value.
The GM relative magnitude had a tendency to be
lower in the diabetic groups compared to Group C, with
significant differences only for MoN and SN. Only
Group SN showed a delay in GM peak activity, although
the difference was not statistically significant when com-
pared to MiN.
The delay in VL was approximately 26% for Groups D
and SN, and these groups had a 28% anticipation of TA
onset when compared to Group C, which was more
pronounced than the 16% for Groups MiN and MoN
(Figure 4). In Group SN, temporal change of GM peak
was more subtle than in the other muscles, with an
average of 6% delay (Figure 4).
Discussion
The aim of this study was to investigate EMG pat-
terns during gait in diabetic individuals with different
stages of DSP severity, classified by a fuzzy system. The
main findings indicate that diabetes mellitus and DSP
are related to changes in muscle activity, although the
alterations did not follow a distal to proximal order [25],
nor did they progress in the same manner from mild to
severe stages. In general, diabetic individuals display
Figure 3 Variables extracted from EMG linear envelopes. Data extracted from the EMG linear envelopes for the calculation of the analyzed
variables: peak and minimum activity of vastus lateralis (VL1 and VL2, respectively), tibialis anterior (TA1 and TA2) and gastrocnemius medialis
(GM1 and GM2); activation magnitude of tibialis anterior at the end of stance phase (TA3), and onset of gastrocnemius medialis (GMon) and
tibialis anterior (TAon).
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altered muscle activity even before the onset of DSP,
suggesting an impaired shock absorption mechanism
at the heel strike and flat-foot phases. In later disease
stages, the muscles related to the propulsion phase are
also affected.
Sacco et al. [2,4] and Akashi et al. [3] observed a
delayed peak activation of VL in diabetic individuals
with neuropathy, and in two studies, [3,4] this difference
appeared only in patients with a history of plantar ulcer-
ation, an attribute that was presented by 84% of the
Table 2 EMG temporal and relative magnitude variables (mag) for vastus lateralis (VL), tibialis anterior (TA) and
gastrocnemius medialis (GM)
Control
(n = 30)
Diabetes no-neuropathy
(n = 43)
Mild neuropathy
(n = 30)
Moderate neuropathy
(n = 16)
Severe neuropathy
(n = 28)
p
VL Time to peak
(% stance)
9.7 ± 3.2* 12.1 ± 2.3*§ 11.0 ± 3.3 9.7 ± 2.5§ 13.5 ± 3.6a < 0.0011
Mag (VL1/VL2) 8.3 ± 4.0b 11.0 ± 6.5 13.6 ± 10.0* 6.8 ± 3.1c 17.1 ± 15.6* 0.0142
TA Time to peak
(% stance)
3.7 ± 2.0 4.2 ± 2.4 3.6 ± 2.1 2.2 ± 2.0 3.3 ± 2.6 0.0551
Mag (TA1/TA2) 60.9 ± 55.5d 21.3 ± 12.8 24,7 ± 15.7 22.7 ± 20.6 33.4 ± 31.0 0.0432
Onset at push off
(% stance)
90.4 ± 6.1† 72.7 ± 10.8* 79.4 ± 12.5* 76.7 ± 10.5 68.8 ± 4.9a < 0.0012
Mag at push off
(TA3/TA2)
6.0 ± 2.7* 8.1 ± 2.7* 7.1 ± 2.8 7.6 ± 2.0 7.1 ± 2.2 0.0141
GM Time to peak
(% stance)
60.0 ± 6.4 60.5 ± 5.1 61.3 ± 3.9 59.3 ± 4.3 64.0 ± 5.6e 0.0151
Mag (GM1/GM2) 52.8 ± 48.8 33.7 ± 24.0 37.9 ± 24.5 19.2 ± 13.5f 16.0 ± 13.4f < 0.0012
Onset (% stance) 40.4 ± 5.4 37.3 ± 5.4 38.7 ± 8.5 34.8 ± 9.2 38.1 ± 6.1 0.0891
1ANOVA; 2Kruskal-Wallis test;
*, § statistically significant difference between groups; † statistically different group; astatistically different from control, and mild and moderate neuropathy;
bstatistically different from mild and severe neuropathy; cstatistically different from diabetes, and mild and severe neuropathy; dstatistically different from diabetes,
and mild and moderate neuropathy; estatistically different from control, diabetes and moderate neuropathy; fstatistically different from control, diabetes and
mild neuropathy.
Figure 4 Temporal variables with statistically significant differences. Box plot with minimum-maximum range of (a) vastus lateralis time to
peak occurrence; (b) tibialis anterior onset time; (c) gastrocnemius medialis time to peak occurrence. *Statistically significant difference between
groups. ┼ Statistically different group.
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subjects in the SN group, which displayed the same
delay in the VL muscle. Therefore, neuropathy does
seem to be related to this difference in temporal behav-
ior of the VL, and once neural involvement starts, there
is an additional change in the relative magnitude of VL,
with an overall increase in the MiN and SN groups.
Nonetheless, our findings show that this delayed pattern
of VL is present even before the development of DSP,
when only diabetes mellitus is present, indicating that
these changes in VL might not be solely related to
neural damage, but might also be influenced by other
factors [26-28].
Diabetes mellitus itself is related to alterations in muscle
cells due to hyperglycemia, insulin resistance, and accu-
mulation of advanced glycation end-products. These ef-
fects lead to reduced nerve conduction velocity [26], loss
of muscle mass, reduced muscle cross-sectional area,
muscle protein degradation [27], and loss of muscle
strength [28], which could be one of the underlying causes
for most of our findings that occurred in subjects without
neuropathy (D group).
The interesting VL results observed in the diabetic
subjects can be based on the findings of Petrofsky et al.
[29] and Ko et al. [30]. In the Petrofsky et al. [29] study
on gait, diabetics without sensory or muscle strength
deficits presented knee joint acceleration two times
greater at the heel strike than healthy individuals. Fur-
thermore, these diabetic individuals have shown higher
absorptive mechanical work expenditure at the knee
joint and a delay on the instant of the first knee flexion
peak in stance phase [30]. All these previous results,
along with our VL findings, reinforce the notion that
diabetic individuals, even without DSP, have difficulty pro-
ducing proper shock absorption at early stance [2,3,30],
and they exhibit greater participation of the knee in this
function. Interestingly, this pattern seems to be more
pronounced in subjects with severe neuropathy, as they
displayed an increase in VL relative magnitude, an indica-
tion of even greater participation of the knee joint in this
gait cycle phase.
All the diabetic groups in this study showed a lower
relative magnitude of TA, suggesting impaired function
at the heel strike phase when this muscle plays an essen-
tial role in controlling forefoot contact with the ground
and in attenuating the initial impact. This poor TA func-
tion at heel strike can be associated with the previously
described delayed VL pattern at this specific gait phase,
in both the D and SN groups. This gait phase is charac-
terized by impact absorption both at the heel and at the
forefoot, and with these alterations in both pivotal mus-
cles, the shock absorption mechanics may be compro-
mised. This change in pretibial muscles was formerly
shown by a delay in the instant of maximum TA activity
[2,22]. Although our results agree with previous findings
that have not shown any temporal difference between
healthy adults and neuropathic patients, with or without
previous ulceration [3,6], the previous studies did not
measure the magnitude of the EMG signals as we did,
and the lower TA activity observed in the present study
could have a biomechanical effect on the shock absorp-
tion mechanism.
Diabetic individuals, both with and without neuropathy,
are known to have reduced gait velocity, cadence, and
stride length [31,32], which could explain the anticipation
of TA onset in late stance that we observed, as toe-off
would occur earlier, resulting in a short stride length. Still,
this motor pattern, associated with the higher relative
magnitude at late stance observed in diabetics without
neuropathy, may explain the reported lower extension
moments [5,33,34], joint stiffness [35-37], and reduced
plantar flexion at late stance [6,34], all observed
in this population. In addition, in patients with severe
neuropathy, GM presented diminished relative magnitude
and delayed peak activity, which would also contribute to
Figure 5 EMG linear envelopes of vastus lateralis. Mean linear envelopes of the vastus lateralis of all experimental groups, in which a
qualitative analysis shows the delay in peak activity of no-neuropathy, mild and severe neuropathy groups.
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this impaired role of propulsion at late stance. This
temporal GM delay was previously described, even with
imposed gait velocities [6], and has occurred only in
individuals with a history of plantar ulceration [3], an
indication of a worse state of disease, which corresponds
with the more severe diabetics in our study.
The fuzzy model was successful in separating the dif-
ferent levels of DSP, leading to a better definition of the
stage when biomechanical alterations occur, as well as
an understanding of how they develop as neuropathy
worsens. It is clear now that different muscles presented
activation impairments in distinct stages of the disease
progression, with the states of absent (D group) and
early (MiN group) stages of neuropathy causing changes
in shock absorption mechanisms, while later stages
(MoN and SN groups) are associated with the addition
of impairments in the propulsion phase of gait.
Therefore, biomechanical alterations should be more
carefully analyzed in gait studies, considering not only
the presence of DSP, but also the influence of the
diabetes control and its status. It is important to highlight
that this fuzzy model still needs to be validated, compar-
ing its results with a gold standard method, such as nerve
conduction studies, but it already has a high correlation
with the results reached by human experts [17].
Although we found significant differences in muscle
activity patterns, we cannot discard the possible influ-
ence of gait velocity on our results, as all subjects were
instructed to walk at a self-selected cadence, and gait
velocity was not controlled during the experiment. How-
ever, diabetic patients, with or without neuropathy, are
known to walk slowly, with a low cadence and small
steps [29,38], and previous studies that controlled gait
speed and cadence [6,8] found that faster walking caused
an overall anticipation of muscle activity. Another limi-
tation of this study was the higher body mass index
found in the diabetic groups, a factor that could cause
differences in EMG because of skin impedance and low-
pass filtering effect. However, with their mean value
falling under the same classification (overweight), the
effect of resistance to electrical current would be the
same throughout the groups. In addition, a higher body
mass index is a common characteristic in these pa-
tients; therefore, recruiting this high number of patients
with lower body mass index would be very difficult to
manage.
The biomechanical alterations during diabetic patients’
gait still have many unanswered questions, but it is clear
that neuropathy degree must be taken into account to
analyze them, and the same applies in health systems’
treatment and prevention strategies for this population. In
order to reach more decisive conclusions, future studies on
muscle activity should capture a larger area of the muscle,
as there is heterogeneity in EMG signals throughout the
muscle tissue due to the disease [25,39]. In addition, other
methods of signal processing should be used, possibly
extracting information on conduction velocity and spectral
properties.
Conclusion
The activity levels of lower limb muscles during gait
changed at distinct severity degrees of DSP. There is
a delay in VL peak activity and reduced TA relative
magnitude that are present even before neurological
involvement, suggesting an impairment in the shock
absorption mechanism at the ankle and a higher
dependence on the knee´s absorptive function in the
weight acceptance phase of gait in the early stages of
the disease. With the onset of neuropathy, this prox-
imal compensation continues, with an increase in VL
relative magnitude. At late stance, TA onset is antici-
pated even in the absence of DSP, with an intensifica-
tion of this pattern in severe neuropathy state, along
with peak delay and lower activation of GM in the
moderate and severe groups.
DSP severity degree must be taken into account when
analyzing the biomechanics of locomotion of diabetic
patients, and we recommend the use of a fuzzy system
to assess the state of disease, not only for research pur-
poses, but also in the healthcare system.
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